title: Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
authors.forename: T
authors.initials: T
authors.lastname: Tachibana
authors.forename: H
authors.initials: H
authors.lastname: Takasaki
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: A
authors.initials: A
authors.lastname: Maruta
authors.forename: R
authors.initials: R
authors.lastname: Hyo
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigatsubo
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
mesh_terms: D000293:Adolescent; D000328:Adult; D000465:Algorithms; D000753:Anemia, Refractory / Q000150:complications*; D005260:Female; D005293:Ferritins / Q000097:blood*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019190:Iron Overload / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors; D016019:Survival Analysis; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D005293:Ferritins